Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2

[1]  J. Isner,et al.  Therapeutic Angiogenesis for Coronary Artery Disease , 2002, Annals of Internal Medicine.

[2]  H. Blau,et al.  VEGF gene delivery to myocardium: deleterious effects of unregulated expression. , 2000, Circulation.

[3]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[4]  Napoleone Ferrara,et al.  VEGF and the quest for tumour angiogenesis factors , 2002, Nature Reviews Cancer.

[5]  C. Stiles,et al.  Retinoic acid promotes transcription of the platelet-derived growth factor alpha-receptor gene , 1990, Molecular and cellular biology.

[6]  Peter Carmeliet,et al.  Growing better blood vessels , 2001, Nature Biotechnology.

[7]  J. Folkman.  Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. , 1995, The New England journal of medicine.

[8]  P O Byrne,et al.  A laser Doppler scanner for imaging blood flow in skin. , 1991, Journal of biomedical engineering.

[9]  B R Johansson,et al.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.

[10]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[11]  Stanley J. Wiegand,et al.  Vascular-specific growth factors and blood vessel formation , 2000, Nature.

[12]  T. Henry,et al.  Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial , 2002, Circulation.

[13]  Peter Carmeliet,et al.  VEGF gene therapy: stimulating angiogenesis or angioma-genesis? , 2000, Nature Medicine.

[14]  C. Heldin,et al.  The Expression of PDGF α- and β-Receptors in Subpopulations of PDGF-Producing Cells Implicates Autocrine Stimulatory Loops in the Control of Proliferation in Cytotrophoblasts that Have Invaded the Maternal Endometrium , 1992 .

[15]  R. Hendel,et al.  Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. , 2000, Circulation.

[16]  M. Mercola,et al.  Distribution and functions of platelet-derived growth factors and their receptors during embryogenesis. , 1997, International review of cytology.

[17]  H. Dvorak,et al.  Angiogenesis Therapy: Amidst the Hype, the Neglected Potential for Serious Side Effects , 2001, Circulation.

[18]  C. Heldin,et al.  Immunoglobulin-like Domain 4-mediated Receptor-Receptor Interactions Contribute to Platelet-derived Growth Factor-induced Receptor Dimerization* , 1997, The Journal of Biological Chemistry.

[19]  Napoleone Ferrara,et al.  Clinical applications of angiogenic growth factors and their inhibitors , 1999, Nature Medicine.

[20]  A. Ullrich,et al.  Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors , 1986, Nature.

[21]  M. Dake,et al.  Vascular endothelial growth factor enhances atherosclerotic plaque progression , 2001, Nature Medicine.

[22]  U. Bagge,et al.  An evaluation of resting arterial ischemia models in the rat hind limb. , 1985, The Journal of cardiovascular surgery.

[23]  J. Waltenberger.  Modulation of growth factor action: implications for the treatment of cardiovascular diseases. , 1997, Circulation.

[24]  J. Isner.  Myocardial gene therapy , 2002, Nature.

[25]  H. Dvorak,et al.  VPF/VEGF and the angiogenic response. , 2000, Seminars in perinatology.

[26]  A. Passaniti,et al.  Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix , 1992, International journal of cancer.

[27]  K. Alitalo,et al.  Vascular endothelial growth factor C induces angiogenesis in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Abel.  Clinical applications of research on angiogenesis , 1996 .

[29]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[30]  J. Folkman,et al.  Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. , 1984, Science.